Tien Liang Biotech Co., Ltd.(TW:4127)
NT$36.150.00 (0.00%)
TW:4127
Tien Liang Biotech Co., Ltd. financials statements
NT$36.15
At close:0.00 (0.00%)
Tien Liang Biotech Co., Ltd. (4127) Income Statement
Tien Liang Biotech Co., Ltd. Income Statement
Last quarter (Q2 2026), Tien Liang Biotech Co., Ltd.'s total revenue was NT$184.74M, an increase of 45.09% from the same quarter last year. In Q2, Tien Liang Biotech Co., Ltd.'s net income was NT$14.15M. See Tien Liang Biotech Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 511.79M | NT$ 385.21M | NT$ 459.99M | NT$ 528.52M | NT$ 571.32M | |
| NT$ 277.86M | NT$ 229.91M | NT$ 286.15M | NT$ 336.55M | NT$ 338.28M | |
| NT$ 294.00M | NT$ 229.32M | NT$ 265.71M | NT$ 278.26M | NT$ 295.33M | |
| Depreciation and Amortization | NT$ 10.07M | NT$ 9.31M | NT$ 10.55M | NT$ 11.05M | NT$ 12.43M |
| NT$ -6.07M | NT$ 25.49M | NT$ 31.05M | NT$ 72.15M | NT$ 63.06M | |
| NT$ -16.14M | NT$ 593.00K | NT$ 20.44M | NT$ 61.10M | NT$ 50.63M | |
| NT$ 4.39M | NT$ 12.50M | NT$ -2.02M | NT$ 1.04M | NT$ 5.84M | |
| NT$ -11.75M | NT$ 13.10M | NT$ 18.42M | NT$ 59.33M | NT$ 48.78M | |
| NT$ -10.25M | NT$ 11.70M | NT$ 17.73M | NT$ 59.48M | NT$ 46.60M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -0.22 | NT$ 0.26 | NT$ 0.39 | NT$ 1.30 | NT$ 1.02 |
| Diluted EPS | NT$ -0.22 | NT$ 0.26 | NT$ 0.39 | NT$ 1.30 | NT$ 1.02 |
| Weighted Average Shares Outstanding | 45.76M | 45.76M | 45.76M | 45.76M | 45.76M |
| Weighted Average Shares Outstanding (Diluted) | 45.76M | 45.77M | 45.79M | 45.76M | 45.76M |
Currency in TWD
